Size Exclusion BioHPLC Columns

Similar documents
BioHPLC columns. Tim Rice Biocolumn Technical Specialist

Agilent AdvanceBio SEC Columns for Aggregate Analysis: Instrument Compatibility

ProSEC 300S. Protein Characterization columns

R R Innovation Way P/N SECKIT-7830 Newark, DE 19711, USA Tel: Fax: Website: Published in November 2013

Separate and Quantify Rituximab Aggregates and Fragments with High-Resolution SEC

Physical Stability of a Silica- Based Size Exclusion Column for Antibody Analysis

2012 Waters Corporation 1

Analysis of biomolecules by SEC and Ion-Exchange UPLC

High-throughput and Sensitive Size Exclusion Chromatography (SEC) of Biologics Using Agilent AdvanceBio SEC Columns

Choosing the Right Calibration for the Agilent Bio SEC-3 Column

ADVANCE ACCURACY AND PRODUCTIVITY FOR FASTER ANALYSIS

Next Generation Zirconia-Based Antibody Purification Media

Superdex 200 Increase columns

Protein Quantitation using various Modes of High Performance Liquid Chromatography

'Tips and Tricks' for Biopharmaceutical Characterization using SEC

HIC as a Complementary, Confirmatory Tool to SEC for the Analysis of mab Aggregates

Separation of Recombinant Human Erythropoietin (repo) Using Agilent Bio SEC-3

Application Note. Author. Abstract. Biopharmaceuticals. Verified for Agilent 1260 Infinity II LC Bio-inert System. Sonja Schneider

Size Exclusion Chromatography

Molecular Characterization of Biotherapeutics The Agilent 1260 Infi nity Multi-Detector Bio-SEC Solution with Advanced Light Scattering Detection

Analysis of Intact and C-terminal Digested IgG1 on an Agilent Bio MAb 5 µm Column

mabs and ADCs analysis by RP

Lifetime stability of size exclusion chromatography columns for protein aggregate analysis

Characterization of mab aggregation using a Cary 60 UV-Vis Spectrophotometer and the Agilent 1260 Infinity LC system

Bio-Monolith Protein G Column - More Options for mab Titer Determination

Size Exclusion Chromatography of Biosimilar and Innovator Insulin Using the Agilent AdvanceBio SEC column

Capillary Electrophoresis of Proteins

A universal chromatography method for aggregate analysis of monoclonal antibodies

Gel Filtration Calibration Kits

mab Titer Analysis with the Agilent Bio-Monolith Protein A Column

Promix TM. Enter a New Era in Biomolecule Analysis with. Columns. Unsurpassed Selectivity and Peak Capacity for Peptides and Proteins

AZURA Bio LC. 2 FPLC and Purification Solutions

Ion Exchange Chromatography Media. Cellufine IEX. Technical Data Sheet

Fast mass transfer Fast separations High throughput and improved productivity Long column lifetime Outstanding reproducibility Low carryover

Disulfide Linkage Analysis of IgG1 using an Agilent 1260 Infinity Bio inert LC System with an Agilent ZORBAX RRHD Diphenyl sub 2 µm Column

Development of Analysis Methods for Therapeutic Monoclonal Antibodies Using Innovative Superficially Porous Particle Biocolumns

Superdex 75 Increase columns

TSKgel STAT Columns for High Performance Ion Exchange Chromatography

ACQUITY UPLC Protein BEH SEC Columns and Standards

Fast and High Resolution Analysis of Intact and Reduced Therapeutic Monoclonal Antibodies (mabs)

3. Close the bottom end of the column and apply the packing device on top. Pump water through the upper adaptor to remove air.

Userguide: SepFast Gel Filtration columns

INSECT CELL/BACULOVIRUS PRODUCTION

Size-Exclusion Chromatography (SEC) Optimization Guide

PRINCIPLES OF CHROMATOGRAPHY SEC COLUMNS

High Resolution Analysis of Heparin and Heparin-like Impurities on Glycomix TM an Anion Exchange Column

MAbPac SCX-10 Columns

An effective platform for purification of IgM monoclonal antibodies using Hydroxyapatite

Polishing of monoclonal antibodies using Capto S ImpAct

Application of Agilent AdvanceBio Desalting-RP Cartridges for LC/MS Analysis of mabs A One- and Two-dimensional LC/MS Study

Protein-Pak Hi Res HIC Column and HIC Protein Standard

Technical Data. Analytical Data

Agilent BioHPLC Columns PROTEIN IDENTIFICATION AND IMPURITY PROFILING USING REVERSED-PHASE HPLC/UHPLC

Econo-Pac High Capacity Ion Exchange Cartridges, 5 ml Instruction Manual. Catalog Numbers , ,

Zwitterion Chromatography ZIC

Types of chromatography

A Fast and Robust Linear ph Gradient Separation Platform for Monoclonal Antibody (MAb) Charge Variant Analysis

Cell Clone Selection Using the Agilent Bio-Monolith Protein A Column and LC/MS

Sepax Technologies, Inc.

BioPro IEX Resins. Resin Downstream Purification

Molecules are separated by size. Small molecules enter pores of stationary phase (b), large molecules do not (a) Larger molecules elute first

HiLoad Superdex 30 prep grade HiLoad Superdex 75 prep grade HiLoad Superdex 200 prep grade

TSKgel Size Exclusion Chromatography Columns

IgG Purity/Heterogeneity and SDS-MW Assays with High- Speed Separation Method and High Throughput Tray Setup

Bivalirudin Purification:

Nuvia S and Q High-Capacity Ion Exchange Media Instruction Manual

Analysis of amoxicillin and five impurities on the Agilent 1220 Infinity LC System

Application Note. Biopharm. Author. Abstract. Christian Wenz Agilent Technologies, Inc. Waldbronn, Germany

Application Note USD Purification of Mouse IgM from Cell Culture Supernatant by Cation Exchange Chromatography on CM Ceramic HyperD F Sorbent

The practical task of monoclonal IgG purification with CHT TM ceramic hydroxyapatite

Fundamentals and Techniques of Preparative HPLC. Parto Zist Behboud Tel: 42108

Fast and Efficient Peptide Mapping of a Monoclonal Antibody (mab): UHPLC Performance with Superficially Porous Particles

Method Development Considerations for Reversed-Phase Protein Separations

Gel filtration columns and media

Module 16: Gel filtration: Principle, Methodology & applications. Dr. Savita Yadav Professor Department of Biophysics AIIMS, New Delhi

G Sep Size Exclusion Columns

Fast and High-Resolution Reversed-Phase Separation of Synthetic Oligonucleotides

Capture of mouse monoclonal antibodies

Gel Filtration Chromatography. Teaching Kit Manual. GeNei TM. Cat No. New Cat No. KT Revision No.:

Developing Robust and Efficient IEX Methods for Charge Variant Analysis of Biotherapeutics Using ACQUITY UPLC H-Class System and Auto Blend Plus

Analytical Instrument Qualification According to USP <1058>: Requirements and Examples for the Agilent 1290 Infinity LC System

Fraction Analysis of Cysteine Linked Antibody-Drug Conjugates Using Hydrophobic Interaction. chromatography. Agilent 1260 Infinity II Bio-Inert System

The Eshmuno Chromatography Family of Resins

Affi-Gel Protein A MAPS II Kit Instruction Manual

Practical Issues in the Industrial use of Hydroxyapatite for Purification of Monoclonal Antibodies

NPTEL VIDEO COURSE PROTEOMICS PROF. SANJEEVA SRIVASTAVA

rprotein A GraviTrap Protein G GraviTrap rprotein A/Protein G GraviTrap

Flexibility with. Preparative HPLC

Electronic Supplementary Information for The effect of protein concentration on the viscosity of a recombinant albumin solution formulation

Genotoxicity is the property of a compound

Combining High Temperature and Small Particles: The Advantages of Zirconia

Maximizing Chromatographic Resolution of Peptide Maps using UPLC with Tandem Columns

electrophoresis tech Performance Comparison of the Experion Automated Electrophoresis System and SDS-PAGE for Protein Analysis

AnaTag HiLyte Fluor 647 Protein Labeling Kit

Application Note. Author. Abstract. Biotherapeutics and Biologics. Sonja Schneider Agilent Technologies, Inc. Waldbronn, Germany

Improved Peptide Maps Using Core-Shell Media: Explaining Better Biopharmaceutical Applications With Kinetex C18 Columns

Peptide Mapping: A Quality by Design (QbD) Approach

1. Bloomsbury BBSRC Centre for Structural Biology, Birkbeck College and University College London.

MATF Antigen Submission Details and Standard Project Deliverables

Transcription:

Size Exclusion BioHPLC Columns Size Exclusion Product Families Particle Porosity Functionalities Particle Pore Size Application Sizes Agilent Bio SEC- Silica Fully porous N/A um 00A, 0A, 00A High efficiency Silica Fully porous N/A um 00A, 0A, 00A More pore sizes 00A, 000A, 000A ProSEC 00S Silica Fully porous N/A um 00A Extend linear range broader sample range ZORBAX GFC Silica Fully porous N/A um, 6um 0A 00A Larger column sizes. High efficiency small particles. Multiple pore sizes to cover broad range of molecular sizes. Single pore size to cover range of globular proteins/antibodies Page 6. Larger columns for fractionation

SEC Applications Non-Denaturing Conditions Separations Based on Size in Solution Impurity testing, aggregation g analysis (separation of monomer/dimer/aggregates) Molecular weight characterization over wide MW range (000 0M) possible Expression and folding studies Separation of Reaction Components and Products, (conjugates) Purification Desalting and salt exchange Collection of fractions under non-denaturing conditions Page 6 SEC Technique Technique is isocratic No interaction with the stationary phase Separation based on differences in size Eluent contains buffer and salt Technique does not denature proteins 0,000 µv 00,000 0,000 00,000 0,000 00,000 0,000 00,000 0,000 00,000 0,000 Decreasing size R&D Bio SEC.DATA Smaller molecules spend longer in the pores and elute later. Larger molecules spend less time in the pores and elute sooner. 0 RT [min] 0 Gel Filtration Standard ( vial diluted with mls of eluent) (Thyroglobulin, -globulin, ovalbumin, myoglobin & vitamin B) 6 7 8 9 0

Elution Profiles If sample molecules have the same molecular dimensions, they will coelute and may not be separated by this technique If two molecules have the same molecular weight but different size in solution they may be separated The calibration curve describes how different size molecules elute fromthecolumnandcanbeusedto determine molecular weight equivalents based on solution size Choose the Appropriate Pore Size Pore Size MW Range Typical Sample (Globular Protein) 00Å 00 00,000 Small proteins 0Å 00 0,000 Small proteins 00Å,000,0,000 Most protein samples 00Å,000,000,000 Larger proteins and antibodies 000Å 0,000 7,00,000 Very large proteins 000Å > 0,000,000 Very large molecules viruses Lower limit on this column is hard to define, Use only for special applications 6

Example of Choice of Pore Size Data. Thyroglobulin Aggregates-. Thyroglobulin-MW 670KD.. -globulin- MW 8 KD. Ovalbumin- MW KD 6. Myoglobin- MW 7KD 7. Vitamin B-MW.KD Eluent: Columns: Flow: Detector: System: 0mM Na HPO, 0mM NaH PO + 0.M NaCl, ph6.8 Agilent Bio SEC- 00Å, 0Å & 00Å µm.6x00mm 0.ml/min UV@0nm Agilent 60 Infinity Bio-Inert LC System. Dimer.. Monomer... Monomer Fragment.. Azide. Retained Molecule Bio-Rad Gel Filtration Standards Mix 6 7 Mouse IgG 00Å 0Å 00Å 0Å 00Å 00Å 7 Separation of Recombinant EPO-Protein (MW: kda) Agilent BioSEC-, 00A.6 x 00mm Column: Agilent Bio SEC, 00A.6 x 00mm ID Sample: repo protein (0.mg/ml) Buffer: 0mM Na phosphate, ph 7.0 Flow rate: 0.ml/min Temp: C Gradient: isocratic Detection: UV Baseline expansion

Monitoring Aggregation and Impurities (IgG MW; 0,000 Da) BioSEC- 00Å, Phosphate buffer to control ph and provide ionic strength Optimized to eliminate interactions 0.0 Column: Bio SEC- 00Å, 7.8x00mm Mobile phase: 0 mm Phosphate, ph 7 0.00 Flow rate:.0 ml/min Temperature: Ambient 0.0 Sample: Monoclonal antibody (0 L, mg/ml) 0.00 0.0 0.00 0.00 MAb Aggregates MAb Dimer Low Molecular Weight Impurities Buffer/Excipients 0.000-0.00.00.00.00.00.00 6.00 7.00 8.00 9.00 0.00.00.00.00.00.00 utes 9 Match Particle Size to Flow Rate and Column Pressure Pressure Increasing flow rate reduces efficiency and resolution.0ml/min.ml/min.0 ml/min monomer dimer Flow Rate Particle Size Column: Agilent Bio SEC-, 7.8 x0mm Sample: mab (mg/ml) Injection: ul Flow rate:.0,. and ml/min (6 bar, 7 bar, 0 bar) Eluent: 0mM sodium phosphate + 00mM Na-sulfate Detection: 0nm Flow Rate Resolution Monomer/Dimer Monomer Efficiency Percentage Dimer.0ml/min.,0 0.6.ml/min.,0 0. 7 utes.0ml/min.,97 0.6 0

Agilent NEW Size Exclusion Columns Agilent Bio SEC- Unique, m particle 00Å, 0Å, 00Å pore sizes Highest resolution Highest efficiency Faster SEC separations m Particle 00Å, 0Å, 00Å, 00Å, 000Å, 000Å pore sizes High stability and long lifetime Great reproducibility Comparing Agilent Bio SEC- and Bio SEC- Improved Efficiency With Smaller Particles Agilent Bio SEC-, 00Å, 7.8x00mm Column Pressure Bio SEC- (7.8x00mm) 9 bar Bio SEC- (7.8x00mm) bar Peak Protein SEC-, 00Å (7.8x00mm) SEC-, 00Å (7.8x00mm) Thyroglobulin 60 0 BSA Dimer 00 70 BSA 090 690 Ribonuclease A 000 60 Uracil 800 7860, 00Å, 7.8x00mm 0 6 7 8 9 0 Column: Bio SEC- 00Å and Bio SEC- 00Å Buffer: 0 mm Phosphate buffer, ph 7 Flow rate:.0 ml/min for 7.8x00 mm Temperature: Ambient (~ C) Detection: UV nm Injection: 0 µl ( L for.6x00 mm) Sample: ) Thyroglobulin (.0 mg/ml), 670 kd; ) BSA dimer, kd; ) BSA (.0 mg/ml), 66 kd; ) Ribonuclease A (.0 mg/ml),.7 kd, and ) Uracil (. g/ml), 0D. 6

Agilent Bio SEC- Sharp Peaks and High Resolution of Proteins Agilent Bio SEC-, 0Å, 7.8x00mm Agilent Bio SEC-, 00Å, 7.8x00mm 0.0.0.0.0.0.0 6.0 7.0 8.0 9.0 0.0.0.0.0.0.0 Peak Compound SEC- 0Å SEC- 00Å Thyroglobulin 800 60 BSA Dimer 0 0 BSA 60 090 Ribonuclease A 7600 000 Columns: Bio SEC-, 7.8x00 mm Mobile phase: 0 mm Phosphate, ph 7 Flow rate:.0 ml/min Temperature: Ambient (~ C) Detection: UV nm Injection: 0 µl Sample: ) Thyroglobulin (.0 mg/ml), 670 kd ) BSA dimer, kd ) BSA (.0 mg/ml), 66 kd ) Ribonuclease A (.0 mg/ml),.7 kd ) Uracil (. g/ml), 0D Uracil 000 800 Agilent Bio SEC- Bio SEC-, 0Å, Capacity: BSA Loading Test.00 Injection volume: 0 L BSA Concentration.80 (from low to high): mg/ml 60.60 mg/ml mg/ml.0 0 mg/ml.0 0 mg/ml 0 mg/ml.00 0.80 0.60 0.0 00 0.0 Column: Bio SEC-, 0Å, 7.8x00mm Mobile phase: 0 mm Phosphate, ph 7.0 Flow Rate:.0 ml/min Injection volume: 0 µl Detector: nm 0.00 0.0.0.0.0.0.0 6.0 7.0 8.0 9.0 0.0.0.0.0.0.0 7

Agilent Bio SEC- Separations of E. coli lysate Bio SEC- 0Å, 7.8x00mm Bio SEC- 00Å, 7.8x00mm 00 0.0 0.0 0.0 0.0 0.0 0.0 60 6.0 70 7.0 80 8.0 90 9.0 0.00.0.0.0.0.0 Column: Column: Bio SEC- 0Å, 7.8x00mm & Bio SEC- 00Å, 7.8x00mm Mobile phase: 0. M Phosphate, ph 7.0 Flow rate:.0 ml/min Detection: UV nm Temperature: Ambient Injection: 0 µl Sample: E. coli lysate (. mg/ml) Agilent Bio SEC- Monoclonal Antibody Aggregation Monitoring 0.0 Column: Bio SEC- 00Å, 7.8x00mm Mobile phase: 0 mm Phosphate, ph 7 0.00 Flow rate:.0 ml/min Temperature: Ambient 0.0 Sample: Monoclonal antibody (0 L, mg/ml) 0.00 0.0 0.00 0.00 0.000000-0.00.00.00.00.00.00 6.00 7.00 8.00 9.00 0.00.00.00.00.00.00 utes 8

High Capacity and High Resolution Au nm m 00 00 0 0 Å. thyroglobulin,. min. BSA dimer, 6.9 min. BSA monomer, 6.9 min. ribonuclease A, 8.7 min. poly-dl-alanine (- kda), 9.90 min 6. uracil,. min 0 6 8 0 Time (min) nm m 00 0 00 TSK G000SW xl. thyroglobulin,.6 min. BSA dimer, 6. min. BSA monomer, 7.0 min. ribonuclease A, 9. min. poly-dl-alanine (- kda), 0.0 min 6. uracil,.8 min 0 6 8 0 Time (min) High Capacity and High Resolution Columns: Bio SEC-,.6x00 mm Buffer: 0. M Phosphate buffer, ph 7.0 Flow rate: 0. ml/min Detector: UV nm Injection volume: 0 µl.thyroglobulin. -Globulin. Ovalbumin. Ribonuclease A. p-aminobenzoic acid Bio SEC-, 0Å Bio SEC-, 00Å Bio SEC-, 00Å 0.00.00.00 6.00 8.00 0.00.00.00 9

High Molecular Weight Protiens 0. Column: Bio SEC-, 000Å,.6x00mm Buffer:0 mm phosphate buffer, ph 7.0 0.0 Flow rate: 0. ml/min Detection: nm 0.8 Temperature: Ambient 0.6 0. Proteins:.Thyroglobulin (670kD). Uracil (0D) 0. 0.0 0.08 0.06 0.0 Possible Dimer 0.0 0.00 0 6 8 0 Reproducibility, 00Å, 7.8x00mm Buffer: 0 mm Phosphate buffer, ph 7.0 Flow Rate:.0 ml/min Detector: nm Injection: 0 ul.thyroglobulin. BSA. Ribonuclease A. Uracil.0.0.0.0.0 6.0 7.0 8.0 9.0 0.0.0.0.0.0.0 utes 0

Lot to Lot Reproducibility, 00Å, 7.8x00mm 0.0 0.8 0.6 0. 0. 0.0 0.08 Black: SN 086 Lot# 00907MGB Blue: SN 0 Lot# 0606MG Green: SN 7 Lot# 006CL 0.06 0.0 0.0 0.00 0.00.00.00.00.00.00 6.00 7.00 8.00 9.00 0.00.00.00.00.00.00 utes Lot Thyroglobulin BSA Ribonuclease A Uracil RT Eff. RT Eff. RT Eff. RT Eff. 00907MG 6.7 6 9. 678 0. 7.0 87 0606MG 6.7 7 9. 68 0.6 06. 69 006CL 6.77 60 9.9 6 0.7 8. 6709 Stability at ph 8.. Thyroglobulin. BSA. Ribonuclease A. Uracil Bio SEC-, 00Å,.6x00mm Buffer: 0mM Phosphate, ph 8. Wavelength: nm Flow Rate: 0. ml/min Injection: ul Pre-test, ph7.0 Day AM, ph8. Day PM, ph8. Day AM, ph8. Day PM, ph8. Day AM, ph8. Day 7 AM, ph8. 0 6 7 8 9 0 utes

Stability at ph 8., increasing injection volume.00 Column: Bio SEC-, 00Å, 7.8x00mm, ph 8..80 Sample: BSA Concentration: mg/ml 60.60 Mobile Phase: 0 mm Phosphate, ph 8..0 Flow Rate:.0 ml/min Detector:.0.00 0.80 0.60 0.0 0.0 0.00 0.00 0.0.00.0.00.0.00.0.00.0.00.0 6.00 6.0 7.00 7.0 8.00 8.0 9.00 9.0 0.00 0.0.00 utes Injection volumes ul, 0 ul, 0 ul, 0 ul, and 00 ul Monoclonal Antibody Aggregation Monitoring 0.00 0.08 0.06 0.0 0.0 0.00 0.008 0.006 0.00 0.00 0.000-0.00-0.00-0.006-0.008 Columns: Bio SEC-, 00Å, 7.8x00mm Buffer: 0 mm Phosphate, ph 7 Flow Rate:.0 ml/min Sample: Mab Temperature: Ambient MAb Dimer Mab Aggregates Buffer Peak.0.00.0.0.0 6.0 7.0 8.0 9.0 0.0.0.0.0.0.0

Size Exclusion Separations of E. coli Lysate (Single Columns) Columns: Bio SEC-, 7.8x00mm Buffer: 0 mm Phosphate, ph 7.0 Flow Rate:.0 ml/min Detector: nm Injection: 0 µl (. mg/ml) SEC-, 000Å SEC-, 00Å SEC-, 00Å SEC-, 0Å 0 6 7 8 9 0 Size Exclusion Separations of E. coli Lysate (Columns In Series)...0 Columns: Bio SEC-, 000Å, 7.8x00mm + Bio SEC-, 0Å, 7.8x00mm Buffer: 0 mm Phosphate, ph 7.0 Flow Rate:.0 ml/min Detector: t nm Injection: 0 µl (. mg/ml) 0.8 0.6 0. 0 0. 0.0 0 6 8 0 6 8 0 6 8 0 utes